A detailed history of Sunpointe, LLC transactions in Amgen Inc stock. As of the latest transaction made, Sunpointe, LLC holds 1,016 shares of AMGN stock, worth $267,594. This represents 0.27% of its overall portfolio holdings.

Number of Shares
1,016
Previous 1,171 13.24%
Holding current value
$267,594
Previous $366 Million 10.53%
% of portfolio
0.27%
Previous 0.24%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$309.38 - $337.38 $47,953 - $52,293
-155 Reduced 13.24%
1,016 $327 Million
Q2 2024

Jul 19, 2024

SELL
$262.75 - $319.31 $9,721 - $11,814
-37 Reduced 3.06%
1,171 $366 Million
Q1 2024

Apr 15, 2024

SELL
$268.87 - $324.56 $27,155 - $32,780
-101 Reduced 7.72%
1,208 $343 Million
Q4 2023

Feb 20, 2024

BUY
$255.7 - $288.46 $334,711 - $377,594
1,309 New
1,309 $377 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Sunpointe, LLC Portfolio

Follow Sunpointe, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sunpointe, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sunpointe, LLC with notifications on news.